ArticleFrontiers in oncology2022

Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning.

Wei-Feng Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.